… wild-type cells in competitive repopulation assays [36]. … in monitoring or even predicting
response to IFNα therapy. … improve adherence to treatment without reducing efficacy, and …

… Interferon alpha overrides the deficient adhesion of CML … by polymerase chain reaction in
Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy …

… methods to the monitoring of treatment efficacy and early … Should polymerase chain reaction
analysis to detect minimal residual disease in patients with chronic myelogenous leukemia …

… ): 1) allogeneic stem cell transplant (SCT); 2) interferon alpha (… of chemical structures capable
of competing with the ATP or … efficacy and allow successful strategies in CML outside the …

… are usually detectable by the polymerase chain reaction (PCR) … The assay performance is
monitored by quality control samples … pretreated with interferon alpha. Low levels of residual …

… Baseline reverse transcriptase-polymerase chain reaction is … It acts via competitive inhibition
at the ATP-binding site of the … with other available (peg-interferon alpha-2, omacetaxine, …

… knowledge on monitoring of MRD in CML patients who obtained CCR after … chronic
myelogenous leukemia patients on Interferon-alpha therapy by competitve polymerase chain reaction…

… demonstrated that interferon alpha therapy is indicated and … , or reverse transcription/polymerase
chain reaction (RT/PCR) ampli… , the best way to monitor individual patients and the best …

… real-time reverse transcriptase polymerase chain reaction (QR-PCR) and … Monitoring
IM-treated CML patients with cytogenetic and … treated with imatinib after failure of interferon alpha. …

… , prognosis, treatment, and monitoring of CML. The discovery … through reverse transcriptase
polymerase chain reaction (RT-… and has fewer adverse effects than interferon-alpha (IFN-a)[…